Essetifin SPA 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-05-04 5:22 pm Purchase | 2020-04-30 | 13D | Fennec Pharmaceuticals Inc. FENC | Essetifin SPA | 3,993,694 16.200% | 768,000![]() (+23.81%) | Filing |